Arcara Jeffrey bought CRVS
February 28, 2024 · Form 4 insider transaction
Arcara Jeffrey bought 400,000 shares of Corvus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
400,000
Price
$0.00
Total value
N/A
InsiderArcara Jeffrey
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 28, 2024
Filing dateMarch 1, 2024
Shares owned after400,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from February 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.